Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ETON will decline by -7.51% over the next 2 Weeks and hit $54.44 by Friday, August 28, 2026. In that time frame, ETON's share price is expected to range between $50.56 and $58.59.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 28, 2026 | 52.34 | 54.50 | 56.66 |
| Aug 27, 2026 | 53.18 | 54.97 | 56.77 |
| Aug 26, 2026 | 53.26 | 55.22 | 56.94 |
| Aug 25, 2026 | 53.63 | 55.50 | 57.17 |
| Aug 24, 2026 | 53.68 | 55.28 | 57.01 |
| Aug 21, 2026 | 55.11 | 56.68 | 58.30 |
| Aug 20, 2026 | 55.63 | 57.14 | 58.60 |
| Aug 19, 2026 | 55.89 | 57.39 | 59.03 |
| Aug 18, 2026 | 56.26 | 57.68 | 59.16 |
| Aug 17, 2026 | 55.93 | 57.46 | 59.03 |
ETON shares rose +44.26% in Friday, August 14, 2026's trading session, rising from a previous close of $40.80 to move at $58.86. The stock demonstrated notable intraday movement (see ETON's key stats for a full breakdown), fluctuating between $53.01 and $59.69, a +12.61% trading range. While recent weeks have seen some volatility, ETON has managed to secure a +30.39% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.29M shares changing hands, 1.66M more than the previous session. This amounted to $134.83M in total market activity.
Will ETON Continue Its Downward Trend?
According to analyst ratings and projections for ETON, Eton Pharmaceuticals, Inc. shares are anticipated to decrease by -3.88%, potentially reaching $56.66 per share by August 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for ETON. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the ETON stock forecast, now is not the best time to buy ETON stock because its current trading price is +7.99% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ETON covering social and institutional perspectives.
ETON Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ETON's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 73.56% to 79.10%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 69.37%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 66.44%, points to growing bullish momentum over the long term. Insights into ETON's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Eton Pharmaceuticals Short-Term Forecasts
ETON Forecast For Next 5 Days
Our algorithm anticipates Eton Pharmaceuticals (ETON) stock could hit $64.44 by Aug 21, 2026. This represents a +9.47% fall from today's price, following a -0.71% change over the past five days.
ETON Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Eton Pharmaceuticals, Inc. (ETON) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $65.08, which would mean a +10.57% increase from the current price of $58.86. Projections for this period range from a high of $70.57 to a low of $60.80.
ETON Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Eton Pharmaceuticals's price over the next three months point to a rise. ETON stock is expected to peak at $62.33 on Oct 21, 2026 after potentially dipping to $56.07 on Aug 27, 2026. On average, ETON is likely to trade around $59.29 in the coming 90 days.
Eton Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Eton Pharmaceuticals (ETON) is expected to trade between $56.07 and $66.26 throughout 2026. This would result in an average price of $60.23, potentially offering investors a +2.33% return from current levels.
Eton Pharmaceuticals, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Eton Pharmaceuticals, Inc. (ETON) is positioned to show a strong performance in August 2026. The price is predicted to move between $56.07 and $60.25, settling at an average of $58.30. This could translate to a -0.95% loss.
September 2026
Based on current market signals, Eton Pharmaceuticals, Inc. is projected to trend september 2026. We forecast a trading range from $56.40 to $61.41, with a likely average price of $58.92. Investors could expect a potential return of +0.10%.
October 2026
Our predictive algorithms indicate Eton Pharmaceuticals, Inc. stock may see a shift in October 2026. The expected range spans $57.20–$62.33, with an average target of $59.77. This represents a positive outlook and a possible gain of +1.55%.
November 2026
Analyzing established trends, Eton Pharmaceuticals, Inc. looks set to move in November 2026. Projections place the stock between $57.01 and $62.77, averaging around $60.27. This suggests a +2.40% gain from current levels.
December 2026
Market indicators suggest Eton Pharmaceuticals, Inc. could experience notable changes during December 2026. Prices could fluctuate within $58.86 to $66.26, with a midpoint forecast of $62.81. The stock might deliver a +6.71% gain.
January 2027
Forecasting for January 2027, models estimate that Eton Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $60.07 and $66.07, averaging $62.60. This signals a positive trajectory with potential returns around +6.35%.
February 2027
According to our latest forecast models, Eton Pharmaceuticals, Inc. (ETON) is positioned to show a strong performance in February 2027. The price is predicted to move between $60.50 and $65.07, settling at an average of $62.76. This could translate to a +6.63% gain.
March 2027
Based on current market signals, Eton Pharmaceuticals, Inc. is projected to trend march 2027. We forecast a trading range from $61.43 to $65.83, with a likely average price of $63.59. Investors could expect a potential return of +8.04%.
April 2027
Our predictive algorithms indicate Eton Pharmaceuticals, Inc. stock may see a shift in April 2027. The expected range spans $61.92–$66.89, with an average target of $64.19. This represents a positive outlook and a possible gain of +9.06%.
May 2027
Analyzing established trends, Eton Pharmaceuticals, Inc. looks set to move in May 2027. Projections place the stock between $63.28 and $69.84, averaging around $66.76. This suggests a +13.42% gain from current levels.
June 2027
Market indicators suggest Eton Pharmaceuticals, Inc. could experience notable changes during June 2027. Prices could fluctuate within $63.67 to $69.84, with a midpoint forecast of $66.39. The stock might deliver a +12.79% gain.
July 2027
Forecasting for July 2027, models estimate that Eton Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $64.29 and $69.18, averaging $66.64. This signals a positive trajectory with potential returns around +13.22%.
August 2027
According to our latest forecast models, Eton Pharmaceuticals, Inc. (ETON) is positioned to show a strong performance in August 2027. The price is predicted to move between $65.10 and $69.45, settling at an average of $67.33. This could translate to a +14.39% gain.
ETON's history of dividends and stock splits also plays a role in long-term investor confidence.

